Cliff Asness's ALT Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 63,485 shares of Altimmune, Inc. (ALT) worth $181,566, representing 0.00% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in ALT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 1.14 M shares. Largest reduction occurred in Q3 2026, reducing 1.16 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Altimmune (ALT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Altimmune (ALT) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | -1.16 M | Reduce 94.80% | 63,485 | $2.86 |
| Q2 2026 | +1.14 M | Add 1328.78% | 1.22 M | $3.04 |
| Q1 2026 | +64,307 | Add 304.10% | 85,454 | $3.08 |
| Q4 2025 | +21,147 | New Buy | 21,147 | $3.61 |
| Q1 2025 | -12,577 | Sold Out | 0 | $0.00 |
| Q4 2024 | -11,308 | Reduce 47.34% | 12,577 | $7.21 |
| Q3 2024 | -17,494 | Reduce 42.28% | 23,885 | $6.14 |
| Q2 2024 | -19,315 | Reduce 31.82% | 41,379 | $6.65 |
| Q1 2024 | +60,694 | New Buy | 60,694 | $10.18 |
| Q2 2023 | -21,662 | Sold Out | 0 | $0.00 |
| Q1 2023 | +21,662 | New Buy | 21,662 | $4.22 |
Cliff Asness's Altimmune Investment FAQs
Cliff Asness first purchased Altimmune, Inc. (ALT) in Q1 2023, acquiring 21,662 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Altimmune, Inc. (ALT) for 11 quarters since Q1 2023.
Cliff Asness's largest addition to Altimmune, Inc. (ALT) was in Q2 2026, adding 1,220,949 shares worth $3.71 M.
According to the latest 13F filing for Q3 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 63,485 shares of Altimmune, Inc. (ALT), valued at approximately $181,566.
As of the Q3 2026 filing, Altimmune, Inc. (ALT) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Altimmune, Inc. (ALT) was 1,220,949 shares, as reported at the end of Q2 2026.